Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Not yet recruiting 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 6 Lung Neoplasms 3 Venous Thromboembolism 1 Thoracic Neoplasms 1 Solid Tumor 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Noonan Syndrome 1 Neoplasms by Site 1 Neoplasms 1 Lung Diseases 1 Hereditary Sensory and Autonomic Neuropathies 1 Healthy Participants 1 Colorectal Neoplasms 1 Carcinoma 1 Bronchial Neoplasms 1 Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation 1

Interventions

Fluorouracil 255 Leucovorin 224 Oxaliplatin 218 Irinotecan 206 Bevacizumab 200 Capecitabine 144 Cetuximab 136 Panitumumab 68 Folfox protocol 63 regorafenib 50 Colonoscopy 44 pembrolizumab 42 IFL protocol 39 Radiotherapy 32 Nivolumab 31 Drug Therapy 27 trifluridine tipiracil drug combination 26 Gemcitabine 24 Blood Specimen Collection 23 Chemotherapy, Adjuvant 20 Surveys and Questionnaires 19 Celecoxib 19 Surgical Procedures, Operative 16 durvalumab 15 Neoadjuvant Therapy 15 Cyclophosphamide 14 Cisplatin 14 aflibercept 13 Standard of Care 13 Pemetrexed 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Colorectal Neoplasms × sotorasib × Clear all

NCT05198934 2026-04-27

CodeBreak300

Amgen

Phase 3 Completed

160 enrolled 1 FDA

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡